SNAP stock plunged after weak 2Q FY2025 earnings and disappointing 3Q outlook, largely driven by pricing challenges on its ads platform. AI and ML investments, along with Spotlight and Snapchat+, are driving early engagement gains but need more time to drive higher revenue growth. AR remains a key long-term growth driver, with over 350 million users engaging daily, supported by a fully integrated AR computing stack that differentiates itself from peers.

The Tonix Pharmaceuticals Holding Corp. stock price has pulled back so much, and they hold a clear campaign runway for Tonmya into 2026. Despite approval, TNXP shares dropped due to concerns over valuation, potential dilution, and uncertainty around commercialization and pricing. Tonmya's novel formulation and high unmet need could drive strong adoption, with revenue potential of $219M–$365M annually at modest market penetration.

Palo Alto Networks' NASDAQ: PANW FQ4 release affirmed the market outlook for cybersecurity and its leading position in the industry. The shift to platformization drives growth, margin, outperformance and accelerates business momentum.

TISI shares gain after Q2 results show revenue growth, margin gains and stronger adjusted EBITDA despite a wider y/y net loss.

FLEX's strong data center growth, global scale and strategic acquisitions fuel momentum as fiscal 2026 outlook brightens.

Expeditors shines with dividend sustainability, cost-cutting, and stock gains, while United Parcel Service struggles with weak demand and payout concerns.

Japanese stocks are surging, with DXJ up 21% in 10 months, driven by record buybacks and strong GDP data. DXJ offers currency-hedged exposure to Japanese equities, attractive valuation at 13.4x P/E, and a high 3.5% dividend yield. Momentum is robust, technicals confirm a breakout, and seasonality favors further upside, with a potential target of $140.

CNBC's Angelica Peebles joins 'Money Movers' to discuss Viking Therapy shares plummeting on new obesity drug data.

ASML's stock underperformed the S&P 500 due to trade tensions and China-related order cancellations, but its technology leadership remains intact. Despite €1.4 billion in Chinese order cancellations, ASML delivered strong Q2 results with 31% revenue growth and EPS up 47% year-on-year. Guidance reflects uncertainty, especially regarding China, but ASML still expects 15% sales growth and robust margins for the full year.

Delta's strong liquidity and dividend growth stand out as American Airlines faces debt, labor costs, and a weak earnings outlook.

C's July card delinquencies move up, yet charge-offs ease and remain well below the pre-pandemic levels.

Walmart's stock surged past $100 in 2025, driven by defensive positioning amid recession fears and strong investor demand. Tariffs are creating a regressive tax environment, squeezing Walmart's core lower-income customers but potentially attracting middle-income shoppers seeking value. Despite economic resilience, consumer sentiment is weakening, and inflationary pressures may compress Walmart's margins even as sales could exceed expectations.

Schwab U.S. Dividend Equity ETF™ remains my top defensive pick, offering superior dividend quality and liquidity versus VIG and VYM, despite recent underperformance versus the S&P 500. The SCHD ETF's low technology exposure and focus on defensive sectors provide a strong buffer against potential market corrections and AI-driven volatility. Persistent inflation, hawkish Fed policy, geopolitical tensions, and seasonal market weakness all reinforce my preference for SCHD as a safe haven.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

STT stock has moved up 13.3% YTD, outpacing peers, with growth fueled by acquisitions, fee gains and shareholder rewards.

WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN) announced its financial results for the fiscal quarter ended June 30, 2025, and filed its Form 10-Q with the Securities and Exchange Commission (“SEC”), highlighting improved operational efficiency.

Partnership offers streamlined value creation monitoring and reporting to support decision-making NEW YORK , Aug. 19, 2025 /PRNewswire/ -- S&P Global (NYSE: SPGI) and Maestro, the leading Value Creation Management platform for private equity and a S&P Global Ventures portfolio company, have announced a strategic partnership to deliver enhanced portfolio monitoring capabilities for private equity firms and their portfolio companies. This partnership includes a native integration of the Maestro platform with S&P Global's iLEVEL portfolio monitoring system, enabling automated data entry and streamlined measurement of value creation initiatives.

Viking Therapeutics (VKTX) shares cratered nearly 45% Tuesday when the biopharma firm reported study of its experimental weight-loss pill raised concerns about side effects.

U.S. equities were mixed at midday as the market weighed more corporate earnings reports and news from the chip sector. The Dow Jones Industrial Average was up, while the S&P 500 and Nasdaq fell.

Housing Numbers Come in Mixed.